Chile vs Saudi Arabia: Previously treated cases tested for RR-/MDR-TB
Chile
99.0%
in 2024
Saudi Arabia
98.0%
in 2024
Chile rank
56th
Saudi Arabia rank
58th
Previously treated cases tested for RR-/MDR-TB over time
- Chile
- Saudi Arabia
How they compare
Chile currently reports 99.0% against 98.0% in Saudi Arabia, a difference of 1.0%.
The two have swapped places 4 times across 12 shared years of data; in 2013 it was Chile ahead.
Chile ranks 56th and Saudi Arabia ranks 58th of 180 countries.
Chile has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.9% | 52.2% | 19.6% | Chile |
| 2020s | 85.6% | 70.6% | 15.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Chile or Saudi Arabia?
- Chile, at 99.0% against 98.0% in Saudi Arabia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Chile and Saudi Arabia?
- 1.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Saudi Arabia?
- 12 years are reported by both, from 2013 to 2024.
- How do Chile and Saudi Arabia rank globally for previously treated cases tested for rr-/mdr-tb?
- Chile ranks 56th and Saudi Arabia ranks 58th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.